| 04/29/2026 3:04 PM | Silverback Therapeutics (1671858) Filer | Form DEFA14A | |
| 04/29/2026 3:05 PM | Silverback Therapeutics (1671858) Filer | Form ARS | |
| 03/31/2026 5:43 PM | Silverback Therapeutics (1671858) Subject MILLENNIUM MANAGEMENT LLC (1273087) Filed by | Form SCHEDULE 13G/A | |
| 03/24/2026 3:18 PM | Silverback Therapeutics (1671858) Subject MILLENNIUM MANAGEMENT LLC (1273087) Filed by | Form SCHEDULE 13G | |
| 03/09/2026 5:01 AM | Silverback Therapeutics (1671858) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/09/2026 5:07 AM | Silverback Therapeutics (1671858) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 01/05/2026 3:20 PM | Silverback Therapeutics (1671858) Issuer Tanimoto Sarina (1951291) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/05/2026 3:19 PM | Silverback Therapeutics (1671858) Issuer Lowenthal Richard E (1378550) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/14/2025 5:41 PM | Silverback Therapeutics (1671858) Issuer Shah Pratik (1580787) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/14/2025 5:42 PM | Silverback Therapeutics (1671858) Issuer Chakma Justin (1951238) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/14/2025 5:43 PM | Silverback Therapeutics (1671858) Issuer Dorsey Brian (1380762) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for SBTX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Silverback Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
| 11/12/2025 4:26 PM | Silverback Therapeutics (1671858) Subject Chakma Justin (1951238) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/12/2025 9:56 AM | Silverback Therapeutics (1671858) Subject Chakma Justin (1951238) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/12/2025 10:09 AM | Silverback Therapeutics (1671858) Subject Chakma Justin (1951238) Reporting | Form 144/A | |
| 11/10/2025 5:02 AM | Silverback Therapeutics (1671858) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/10/2025 5:04 AM | Silverback Therapeutics (1671858) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 10/01/2025 8:19 PM | Silverback Therapeutics (1671858) Subject RA CAPITAL MANAGEMENT, L.P. (1346824) Filed by | Form SCHEDULE 13D/A | |
| 09/29/2025 3:15 PM | Silverback Therapeutics (1671858) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/27/2025 8:45 PM | Silverback Therapeutics (1671858) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/22/2025 3:30 PM | Silverback Therapeutics (1671858) Issuer Scott Kathleen D. (1794284) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/22/2025 3:30 PM | Silverback Therapeutics (1671858) Issuer Lowenthal Richard E (1378550) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/21/2025 4:36 PM | Silverback Therapeutics (1671858) Issuer Tanimoto Sarina (1951291) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/21/2025 3:18 PM | Silverback Therapeutics (1671858) Subject Scott Kathleen D. (1794284) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/21/2025 10:20 AM | Silverback Therapeutics (1671858) Subject Lowenthal Richard E (1378550) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/19/2025 9:22 AM | Silverback Therapeutics (1671858) Subject Tanimoto Sarina (1951291) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/13/2025 6:02 AM | Silverback Therapeutics (1671858) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/13/2025 6:03 AM | Silverback Therapeutics (1671858) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 08/01/2025 5:06 PM | Silverback Therapeutics (1671858) Subject Flynn James E (1352546) Filed by | Form SCHEDULE 13D/A | |
| 07/22/2025 6:38 PM | Silverback Therapeutics (1671858) Subject Flynn James E (1352546) Filed by | Form SCHEDULE 13D/A | |
| 07/02/2025 7:24 AM | Silverback Therapeutics (1671858) Subject Flynn James E (1352546) Filed by | Form SCHEDULE 13D/A | |
| 07/01/2025 3:42 PM | Silverback Therapeutics (1671858) Issuer DEERFIELD MANAGEMENT COMPANY, L.P. (0) SERIES C Deerfield Mgmt III, L.P. (1610540) Reporting Deerfield Mgmt IV, L.P. (1713467) Reporting Deerfield Private Design Fund III, L.P. (1603333) Reporting Deerfield Private Design Fund IV, L.P. (1680307) Reporting Flynn James E (1352546) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/27/2025 4:21 PM | Silverback Therapeutics (1671858) Issuer Kolchinsky Peter (1384859) Reporting RA Capital Healthcare Fund LP (1315082) Reporting RA CAPITAL MANAGEMENT, L.P. (1346824) Reporting RA Capital Nexus Fund II, L.P. (1825376) Reporting Shah Rajeev M. (1619841) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/27/2025 3:43 PM | Silverback Therapeutics (1671858) Issuer Dadoo Rajeev (1951685) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/27/2025 3:30 PM | Silverback Therapeutics (1671858) Issuer Shawver Laura (1551891) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/27/2025 3:30 PM | Silverback Therapeutics (1671858) Issuer SCHNEIDER PHILLIP M (1230051) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/27/2025 3:30 PM | Silverback Therapeutics (1671858) Issuer SAUNDERS BRENT L (1268854) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/27/2025 3:30 PM | Silverback Therapeutics (1671858) Issuer Thompson Peter A. (1357522) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/27/2025 3:30 PM | Silverback Therapeutics (1671858) Issuer Islam Saqib (1575408) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/27/2025 3:30 PM | Silverback Therapeutics (1671858) Issuer Kelly Michael (1952533) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/27/2025 3:30 PM | Silverback Therapeutics (1671858) Issuer Shah Pratik (1580787) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/26/2025 3:15 PM | Silverback Therapeutics (1671858) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
| 06/20/2025 5:38 PM | Silverback Therapeutics (1671858) Issuer Karas Eric (1951287) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/18/2025 3:51 PM | Silverback Therapeutics (1671858) Subject Karas Eric (1951287) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 05/20/2025 4:24 PM | Silverback Therapeutics (1671858) Subject Scott Kathleen D. (1794284) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 05/20/2025 3:48 PM | Silverback Therapeutics (1671858) Subject SAUNDERS BRENT L (1268854) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 05/20/2025 3:50 PM | Silverback Therapeutics (1671858) Subject Fitzpatrick Alexander A (1398595) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 05/14/2025 6:01 AM | Silverback Therapeutics (1671858) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/14/2025 6:03 AM | Silverback Therapeutics (1671858) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |